title: Vestibular paroxysmia: a treatable neurovascular cross-compression syndrome.
abstract: The leading symptoms of vestibular paroxysmia (VP) are recurrent, spontaneous, short attacks of spinning or non-spinning vertigo that generally last less than one minute and occur in a series of up to 30 or more per day. VP may manifest when arteries in the cerebellar pontine angle cause a segmental, pressure-induced dysfunction of the eighth nerve. The symptoms are usually triggered by direct pulsatile compression with ephaptic discharges, less often by conduction blocks. MR imaging reveals the neurovascular compression of the eighth nerve (3D constructive interference in steady state and 3D time-of-flight sequences) in more than 95% of cases. A loop of the anterior inferior cerebellar artery seems to be most often involved, less so the posterior inferior cerebellar artery, the vertebral artery, or a vein. The frequent attacks of vertigo respond to carbamazepine or oxcarbazepine, even in low dosages (200-600 mg/d or 300-900 mg/d, respectively), which have been shown to also be effective in children. Alternative drugs to try are lamotrigine, phenytoin, gabapentin, topiramate or baclofen or other non-antiepileptic drugs used in trigeminal neuralgia. The results of ongoing randomized placebo-controlled treatment studies, however, are not yet available. Surgical microvascular decompression of the eighth nerve is the "ultima ratio" for medically intractable cases or in exceptional cases of non-vascular compression of the eighth nerve by a tumor or cyst. The International Barany Society for Neuro-Otology is currently working on a consensus document on the clinical criteria for establishing a diagnosis of VP as a clinical entity.
authors.affiliation: Institute for Clinical Neurosciences, Ludwig-Maximilians University, Munich, Germany. thomas.brandt@med.uni-muenchen.de.|German Center for Vertigo and Balance Disorders, Ludwig-Maximilians University, Munich, Germany. thomas.brandt@med.uni-muenchen.de.
authors.forename: Thomas
authors.initials: T
authors.lastname: Brandt
authors.affiliation: Department of Neurology, Ludwig-Maximilians University, Munich, Germany.|German Center for Vertigo and Balance Disorders, Ludwig-Maximilians University, Munich, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Strupp
authors.affiliation: Department of Neurology, Ludwig-Maximilians University, Munich, Germany.|German Center for Vertigo and Balance Disorders, Ludwig-Maximilians University, Munich, Germany.|Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
authors.forename: Marianne
authors.initials: M
authors.lastname: Dieterich
mesh_terms: D000015:Abnormalities, Multiple; D019465:Craniofacial Abnormalities / Q000150:complications*; D003937:Diagnosis, Differential; D019468:Disease Management; D006801:Humans; D009408:Nerve Compression Syndromes / Q000150:complications*; D010859:Pigmentation Disorders / Q000150:complications*; D016896:Treatment Outcome; D014717:Vertigo / Q000209:etiology* / Q000628:therapy*
keywords: Carbamazepine; Episodic vertigo; Neurovascular cross-compression; Review; Vestibular nerve; Vestibular paroxysmia